TRUTruScreen Group Limited

TRU Stock Price, Valuation & Chart | TruScreen Group Limited

Compare

$0.010+0.00 (+0.00%)

At close · 24 Aug 2026, 03:23 am

Sector: Healthcare TRU intrinsic value Is TRU overvalued or undervalued Website

Overview Financials Dividends Ratios

TRU Historical price chart

TRU Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization9.18M

PE Ratio-3.74

EPS0.0

Trading Volume961

Today's High/Low0.01/0.01

Dividend Yield0.00

52 Week High/Low0.03/0.01

Shares Outstanding705.96M

TRU Financial Statement

TRU Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 0 analysts giving stock ratings to TRU in the past 3 months.

TRU Analysis & performance metrics

TRU Company profile

Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe,…

Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue…

TRU Management team

Name

Position

Edmond CapceleaCTO

Chief Technology Officer

Martin DillonCEO

Chief Executive Officer

. Chuong

Head of Research & Development and Training Department

. Phunc

Head of Cancer Department

Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICDCFO

Chief Financial Officer & Company Secretary

. Thuy

Head of High Service Gynaecology Examination

Name

Position

Edmond CapceleaCTO

Chief Technology Officer

Martin DillonCEO

Chief Executive Officer

. Chuong

Head of Research & Development and Training Department

. Phunc

Head of Cancer Department

Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICDCFO

Chief Financial Officer & Company Secretary

. Thuy

Head of High Service Gynaecology Examination

Management Team

Edmond CapceleaCTO

Chief Technology Officer

Martin DillonCEO

Chief Executive Officer

. Chuong

Head of Research & Development and Training Department

. Phunc

Head of Cancer Department

Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICDCFO

Chief Financial Officer & Company Secretary

. Thuy

Head of High Service Gynaecology Examination

Management

Edmond CapceleaCTO

Chief Technology Officer

Martin DillonCEO

Chief Executive Officer

. Chuong

Head of Research & Development and Training Department

. Phunc

Head of Cancer Department

Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICDCFO

Chief Financial Officer & Company Secretary

. Thuy

Head of High Service Gynaecology Examination

Total 6 executives

TRU Frequently asked questions

What is TruScreen Group Limited (TRU) Stock Price?

Current stock price of TruScreen Group Limited (TRU) stock is $0.010. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of TruScreen Group Limited (TRU) stock is 961.

Last updated at 24 Aug 2026, 03:23 am.

Why is the TruScreen Group Limited (TRU) stock price going up or down today?

The stock price of TruScreen Group Limited (TRU) can change with earnings, company news, and overall market sentiment. TruScreen Group Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the TruScreen Group Limited stock expensive at its current price?

Whether TruScreen Group Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TRU on this page is -3.74. EPS on this page is 0.00. Compare those figures with peers and growth expectations before deciding if the current TruScreen Group Limited price is justified.

How has the stock price of TruScreen Group Limited (TRU) performed historically?

Historical performance for TruScreen Group Limited (TRU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TRU reacted to past earnings and market events.

Should I buy TruScreen Group Limited (TRU) stock, at this price?

Buying TruScreen Group Limited (TRU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.